The LNP-mRNA modality is a novel approach that uses lipid nanoparticles to deliver messenger RNA into cells. The mRNA acts as ...

A research team from POSTECH has developed a biodegradable polymer-based delivery system that efficiently transports mRNA.

LNP that are used today for mRNA therapies are up to 200,000-250,000 times more active than those that were originally developed for small interfering RNA therapies. In addition, the LNP has also ...

mRNA vaccines offer clear advantages and disadvantages ... “In addition, advances in delivery technologies over current gold-standard LNP approaches to improve immunogenicity and reduce dosing ...

Scientists have progressed from merely provoking an anti-cancer immune response to designing it ...

Safety and efficacy of the IV mRNA lipid nanoparticle (LNP) product has already been demonstrated in preclinical development studies. The company said it has proven the safety and efficacy of its ...

Currently, Andersson explained, the gold standard for efficient delivery of mRNA is lipid nano particles (LNP). However, she notes, repeated dosing of mRNA can result in an immunogenic response to ...

The mRNA vaccine against avian influenza presents several advantages and disadvantages: Advantages: Rapid Development and Production; Non-Infectious Nature; Strong Immune Response; Adaptability to ...

Researchers have found a new way to reduce the effects of pre-eclampsia using mRNA-lipid nanoparticle therapies.

Editor’s note: This story was reported and edited by independent journalists commissioned by LNP | LancasterOnline. To avoid a conflict of interest, neither newsroom management nor the reporting ...

Ethris GmbH, a leading biotechnology company pioneering next-generation RNA therapeutics and vaccines, today announced promising topline data from the completed Phase 1 clinical trial of its lead mRNA ...